Selected research
Industry Research
AI in Pathology Industry Research Report 2026
Market perspective
The global AI in Pathology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI in Pathology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI in Pathology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI in Pathology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI in Pathology include Koninklijke Philips N.V., F.Hoffmann-La Roche Ltd., Hologic, Inc., Visiopharm A/S, Paige AI, Inc., PathAI, Inc., Aiforia Technologies Plc, Indica Labs, Inc. and Optrascan, Inc. (Optra Ventures, LLC) and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI in Pathology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI in Pathology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI in Pathology Market by Company
Koninklijke Philips N.V.
F.Hoffmann-La Roche Ltd.
Hologic, Inc.
Visiopharm A/S
Paige AI, Inc.
PathAI, Inc.
Aiforia Technologies Plc
Indica Labs, Inc.
Optrascan, Inc. (Optra Ventures, LLC)
MindPeak GmbH
AI in Pathology Segment by Type
Convolutional neural networks (CNNs)
Generative adversarial networks (GANs)
Recurrent neural networks (RNNs)
Others
AI in Pathology Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Reference Laboratories
Academic & Research Institutes
AI in Pathology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Pathology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI in Pathology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Pathology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI in Pathology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Convolutional neural networks (CNNs)
- Generative adversarial networks (GANs)
- Recurrent neural networks (RNNs)
- Others
Applications
- Pharmaceutical & Biotechnology Companies
- Hospitals & Reference Laboratories
- Academic & Research Institutes
Companies covered
- Koninklijke Philips N.V.
- F.Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Visiopharm A/S
- Paige AI, Inc.
- PathAI, Inc.
- Aiforia Technologies Plc
- Indica Labs, Inc.
- Optrascan, Inc. (Optra Ventures, LLC)
- MindPeak GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI in Pathology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Convolutional neural networks (CNNs)
- 2.2.3 Generative adversarial networks (GANs)
- 2.2.4 Recurrent neural networks (RNNs)
- 2.2.5 Others
- 2.3 AI in Pathology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical & Biotechnology Companies
- 2.3.3 Hospitals & Reference Laboratories
- 2.3.4 Academic & Research Institutes
- 2.4 Assumptions and Limitations
3 AI in Pathology Breakdown Data by Type
- 3.1 Global AI in Pathology Historic Market Size by Type (2021-2026)
- 3.2 Global AI in Pathology Forecasted Market Size by Type (2027-2032)
4 AI in Pathology Breakdown Data by Application
- 4.1 Global AI in Pathology Historic Market Size by Application (2021-2026)
- 4.2 Global AI in Pathology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI in Pathology Market Perspective (2021-2032)
- 5.2 Global AI in Pathology Growth Trends by Region
- 5.2.1 Global AI in Pathology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI in Pathology Historic Market Size by Region (2021-2026)
- 5.2.3 AI in Pathology Forecasted Market Size by Region (2027-2032)
- 5.3 AI in Pathology Market Dynamics
- 5.3.1 AI in Pathology Industry Trends
- 5.3.2 AI in Pathology Market Drivers
- 5.3.3 AI in Pathology Market Challenges
- 5.3.4 AI in Pathology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI in Pathology Players by Revenue
- 6.1.1 Global Top AI in Pathology Players by Revenue (2021-2026)
- 6.1.2 Global AI in Pathology Revenue Market Share by Players (2021-2026)
- 6.2 Global AI in Pathology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI in Pathology Head Office and Area Served
- 6.4 Global AI in Pathology Players, Product Type & Application
- 6.5 Global AI in Pathology Manufacturers Established Date
- 6.6 Global AI in Pathology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI in Pathology Market Size (2021-2032)
- 7.2 North America AI in Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI in Pathology Market Size by Country (2021-2026)
- 7.4 North America AI in Pathology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI in Pathology Market Size (2021-2032)
- 8.2 Europe AI in Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI in Pathology Market Size by Country (2021-2026)
- 8.4 Europe AI in Pathology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI in Pathology Market Size (2021-2032)
- 9.2 Asia-Pacific AI in Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI in Pathology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI in Pathology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI in Pathology Market Size (2021-2032)
- 10.2 South America AI in Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI in Pathology Market Size by Country (2021-2026)
- 10.4 South America AI in Pathology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI in Pathology Market Size (2021-2032)
- 11.2 Middle East & Africa AI in Pathology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI in Pathology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI in Pathology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Koninklijke Philips N.V.
- 12.1.1 Koninklijke Philips N.V. Company Information
- 12.1.2 Koninklijke Philips N.V. Business Overview
- 12.1.3 Koninklijke Philips N.V. Revenue in AI in Pathology Business (2021-2026)
- 12.1.4 Koninklijke Philips N.V. AI in Pathology Product Portfolio
- 12.1.5 Koninklijke Philips N.V. Recent Developments
- 12.2 F.Hoffmann-La Roche Ltd.
- 12.2.1 F.Hoffmann-La Roche Ltd. Company Information
- 12.2.2 F.Hoffmann-La Roche Ltd. Business Overview
- 12.2.3 F.Hoffmann-La Roche Ltd. Revenue in AI in Pathology Business (2021-2026)
- 12.2.4 F.Hoffmann-La Roche Ltd. AI in Pathology Product Portfolio
- 12.2.5 F.Hoffmann-La Roche Ltd. Recent Developments
- 12.3 Hologic, Inc.
- 12.3.1 Hologic, Inc. Company Information
- 12.3.2 Hologic, Inc. Business Overview
- 12.3.3 Hologic, Inc. Revenue in AI in Pathology Business (2021-2026)
- 12.3.4 Hologic, Inc. AI in Pathology Product Portfolio
- 12.3.5 Hologic, Inc. Recent Developments
- 12.4 Visiopharm A/S
- 12.4.1 Visiopharm A/S Company Information
- 12.4.2 Visiopharm A/S Business Overview
- 12.4.3 Visiopharm A/S Revenue in AI in Pathology Business (2021-2026)
- 12.4.4 Visiopharm A/S AI in Pathology Product Portfolio
- 12.4.5 Visiopharm A/S Recent Developments
- 12.5 Paige AI, Inc.
- 12.5.1 Paige AI, Inc. Company Information
- 12.5.2 Paige AI, Inc. Business Overview
- 12.5.3 Paige AI, Inc. Revenue in AI in Pathology Business (2021-2026)
- 12.5.4 Paige AI, Inc. AI in Pathology Product Portfolio
- 12.5.5 Paige AI, Inc. Recent Developments
- 12.6 PathAI, Inc.
- 12.6.1 PathAI, Inc. Company Information
- 12.6.2 PathAI, Inc. Business Overview
- 12.6.3 PathAI, Inc. Revenue in AI in Pathology Business (2021-2026)
- 12.6.4 PathAI, Inc. AI in Pathology Product Portfolio
- 12.6.5 PathAI, Inc. Recent Developments
- 12.7 Aiforia Technologies Plc
- 12.7.1 Aiforia Technologies Plc Company Information
- 12.7.2 Aiforia Technologies Plc Business Overview
- 12.7.3 Aiforia Technologies Plc Revenue in AI in Pathology Business (2021-2026)
- 12.7.4 Aiforia Technologies Plc AI in Pathology Product Portfolio
- 12.7.5 Aiforia Technologies Plc Recent Developments
- 12.8 Indica Labs, Inc.
- 12.8.1 Indica Labs, Inc. Company Information
- 12.8.2 Indica Labs, Inc. Business Overview
- 12.8.3 Indica Labs, Inc. Revenue in AI in Pathology Business (2021-2026)
- 12.8.4 Indica Labs, Inc. AI in Pathology Product Portfolio
- 12.8.5 Indica Labs, Inc. Recent Developments
- 12.9 Optrascan, Inc. (Optra Ventures, LLC)
- 12.9.1 Optrascan, Inc. (Optra Ventures, LLC) Company Information
- 12.9.2 Optrascan, Inc. (Optra Ventures, LLC) Business Overview
- 12.9.3 Optrascan, Inc. (Optra Ventures, LLC) Revenue in AI in Pathology Business (2021-2026)
- 12.9.4 Optrascan, Inc. (Optra Ventures, LLC) AI in Pathology Product Portfolio
- 12.9.5 Optrascan, Inc. (Optra Ventures, LLC) Recent Developments
- 12.10 MindPeak GmbH
- 12.10.1 MindPeak GmbH Company Information
- 12.10.2 MindPeak GmbH Business Overview
- 12.10.3 MindPeak GmbH Revenue in AI in Pathology Business (2021-2026)
- 12.10.4 MindPeak GmbH AI in Pathology Product Portfolio
- 12.10.5 MindPeak GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst